CIK: 0001687078 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $610,879 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MDGL | Madrigal Pharmaceuticals Inc | 100,415 | $46,056 | 7.5% | $328.59 | +13.5% | Common | 558868105 |
| CGEM | Cullinan Therapeutics, Inc. | 7,648,268 | $45,354 | 7.4% | $40.60 | -82.0% | Common | 230031106 |
| RNAM | Avidity Biosciences Inc | 760,022 | $33,114 | 5.4% | $39.95 | +1.2% | Common | 05370A108 |
| TRVI | Trevi Therapeutics Inc | 3,406,955 | $31,174 | 5.1% | $2.95 | +154.0% | Common | 89532M101 |
| EWTX | Edgewise Therapeutics Inc | 1,720,741 | $27,910 | 4.6% | $17.71 | -19.9% | Common | 28036F105 |
| PTCT | PTC Therapeutics Inc | 438,477 | $26,909 | 4.4% | $40.98 | +27.1% | Common | 69366J200 |
| ZLAB | Zai Lab Ltd | 745,060 | $25,250 | 4.1% | $26.59 | — | ADR | 98887Q104 |
| SNDX | Syndax Pharmaceuticals Inc | 1,375,674 | $21,165 | 3.5% | $13.09 | 0.0% | Common | 87164F105 |
| ORIC | Oric Pharmaceuticals Inc | 1,729,378 | $20,753 | 3.4% | $8.36 | +25.9% | Common | 68622P109 |
| TARS | Tarsus Pharmaceuticals Inc | 341,496 | $20,295 | 3.3% | $45.00 | +9.4% | Common | 87650L103 |
| XENE | Xenon Pharmaceuticals Inc | 503,398 | $20,211 | 3.3% | $37.76 | -6.7% | Common | 98420N105 |
| STOK | Stoke Therapeutics Inc | 789,698 | $18,558 | 3.0% | $13.06 | +31.2% | Common | 86150R107 |
| DYN | Dyne Therapeutics, Inc. | 1,446,361 | $18,296 | 3.0% | $11.01 | +3.6% | Common | 26818M108 |
| CMPX | Compass Therapeutics, Inc. | 5,075,970 | $17,766 | 2.9% | $1.57 | +100.6% | Common | 20454B104 |
| ALKS | Alkermes Plc | 549,262 | $16,478 | 2.7% | $31.51 | -10.5% | Common | G01767105 |
| VERA | Vera Therapeutics Inc. | 563,075 | $16,363 | 2.7% | $35.17 | -34.2% | Class A Ord | 92337R101 |
| NTRA | Natera Inc | 98,924 | $15,924 | 2.6% | $76.08 | +107.9% | Common | 632307104 |
| JANX | Janux Therapeutics Inc | 614,282 | $15,013 | 2.5% | $39.90 | -39.0% | Common | 47103J105 |
| RVMD | Revolution Medicines, Inc. | 315,722 | $14,744 | 2.4% | $29.31 | +33.6% | Common | 76155X100 |
| CNTX | Context Therapeutics Inc | 14,705,882 | $14,247 | 2.3% | $1.73 | -53.2% | Common | 21077P108 |
| SRPT | Sarepta Therapeutics Inc | 700,000 | $13,489 | 2.2% | $29.24 | -39.0% | Common | 803607100 |
| SPRY | ARS Pharmaceuticals Inc | 1,303,399 | $13,099 | 2.1% | $12.03 | +19.3% | Common | 82835W108 |
| RCKT | Rocket Pharmaceuticals, Inc. | 3,903,381 | $12,725 | 2.1% | $9.83 | -68.0% | Common | 77313F106 |
| RLAY | Relay Therapeutics Inc. | 2,282,680 | $11,916 | 2.0% | $10.70 | -64.4% | Common | 75943R102 |
| RARE | Ultragenyx Pharmaceutical Inc | 395,700 | $11,903 | 1.9% | $46.13 | -35.0% | Common | 90400D108 |
| WVE | Wave Life Sciences PTE LTD | 1,505,262 | $11,019 | 1.8% | $10.27 | -21.2% | Common | Y95308105 |
| DBVT | DBV Technologies S A | 1,054,504 | $10,545 | 1.7% | $9.15 | — | SPONSORED ADS | 23306J309 |
| SLNO | Soleno Therapeutics Inc | 150,000 | $10,140 | 1.7% | $74.37 | -0.3% | Common | 834203309 |
| SLDB | Solid Biosciences Inc | 1,634,569 | $10,085 | 1.7% | $4.28 | +36.6% | Common | 83422E204 |
| AKBA | Akebia Therapeutics Inc | 2,889,125 | $7,887 | 1.3% | $2.75 | +21.1% | Common | 00972D105 |
| HOWL | Werewolf Therapeutics, Inc. | 2,408,810 | $4,745 | 0.8% | $13.70 | -90.0% | Common | 95075A107 |
| LQDA | Liquidia Corp | 200,000 | $4,548 | 0.7% | $21.69 | 0.0% | Common | 53635D202 |
| PVLA | Palvella Therapeutics Inc | 67,423 | $4,227 | 0.7% | $44.59 | 0.0% | Common | 697947109 |
| DSGN | Design Therapeutics Inc | 555,187 | $4,181 | 0.7% | $5.79 | -13.5% | Common | 25056L103 |
| RNAC | Cartesian Therapeutics Inc | 380,000 | $3,884 | 0.6% | $19.06 | -41.0% | Common | 816212302 |
| ENGN | enGene Holdings Inc | 530,299 | $3,622 | 0.6% | $4.56 | 0.0% | Common | 29286M105 |
| URGN | Urogen Pharma Ltd | 135,000 | $2,693 | 0.4% | $17.96 | 0.0% | Common | M96088105 |
| RAPP | Rapport Therapeutics Inc | 71,807 | $2,133 | 0.3% | $17.84 | 0.0% | Common | 75383L102 |
| — | Repare Therapeutics, Inc. | 819,924 | $1,443 | 0.2% | $31.02 | — | Common | 760273102 |
| ASMB | Assembly Biosciences Inc | 39,665 | $1,015 | 0.2% | $21.94 | 0.0% | Common | 045396207 |